WestEnd Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.61K Buy
19
+1
+6% +$81 ﹤0.01% 210
2026
Q1
$1.27K Hold
18
﹤0.01% 204
2025
Q4
$1.42K Buy
18
+5
+38% +$396 ﹤0.01% 195
2025
Q3
$1.07K Hold
13
﹤0.01% 222
2025
Q2
$1.04K Sell
13
-3
-19% -$232 ﹤0.01% 209
2025
Q1
$1.28K Buy
16
+10
+167% +$832 ﹤0.01% 188
2024
Q4
$491 Buy
6
+1
+20% +$83 ﹤0.01% 175
2024
Q3
$412 Buy
5
+2
+67% +$149 ﹤0.01% 199
2024
Q2
$211 Buy
3
+1
+50% +$71 ﹤0.01% 256
2024
Q1
$148 Buy
+2
New +$139 ﹤0.01% 276
2022
Q1
Sell
-9
Closed -$608 141
2021
Q4
$562 Buy
+9
New +$565 ﹤0.01% 149
2021
Q3
Hold
0
138
2021
Q2
Hold
0
148

Other funds holding MET

WestEnd Advisors's MET Position: Q2 2026 in Review

WestEnd Advisors increased its MetLife (MET) stake by 5.6% in Q2 2026, buying an estimated $81 and bringing the position to 19 shares worth $1.61K. The position accounts for ﹤0.01% of the portfolio, ranked #210.

WestEnd Advisors first reported a position in MET in Q4 2021 and has held it in 11 quarters since. 423 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • WestEnd Advisors held 19 shares of MetLife worth $1.61K as of Q2 2026.
  • WestEnd Advisors bought 1 MetLife share in Q2 2026, an estimated $81.
  • MetLife made up ﹤0.01% of WestEnd Advisors's portfolio in Q2 2026, its #210 holding.
  • WestEnd Advisors first reported a position in MetLife in Q4 2021 and has held it in 11 quarters since.
  • 423 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.